Viral-mediated Inhibition of Antioxidant Enzymes Contributes to the Pathogenesis of Severe Respiratory Syncytial Virus Bronchiolitis

Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infections in children, for which no specific treatment or vaccine is currently available. We have previously shown that RSV induces reactive oxygen species in cultured cells and oxidative injury in the lungs of experiment...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of respiratory and critical care medicine Vol. 183; no. 11; pp. 1550 - 1560
Main Authors HOSAKOTE, Yashoda M, JANTZI, Paul D, ESHAM, Dana L, SPRATT, Heidi, KUROSKY, Alexander, CASOLA, Antonella, GAROFALO, Roberto P
Format Journal Article
LanguageEnglish
Published New York, NY American Thoracic Society 01.06.2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infections in children, for which no specific treatment or vaccine is currently available. We have previously shown that RSV induces reactive oxygen species in cultured cells and oxidative injury in the lungs of experimentally infected mice. The mechanism(s) of RSV-induced oxidative stress in vivo is not known. To measure changes of lung antioxidant enzymes expression/activity and activation of NF-E2-related factor 2 (Nrf2), a transcription factor that regulates detoxifying and antioxidant enzyme gene expression, in mice and in infants with naturally acquired RSV infection. Superoxide dismutase 1 (SOD 1), SOD 2, SOD 3, catalase, glutathione peroxidase, and glutathione S-transferase, as well as Nrf2 expression, were measured in murine bronchoalveolar lavage, cell extracts of conductive airways, and/or in human nasopharyngeal secretions by Western blot and two-dimensional gel electrophoresis. Antioxidant enzyme activity and markers of oxidative cell injury were measured in either murine bronchoalveolar lavage or nasopharyngeal secretions by colorimetric/immunoassays. RSV infection induced a significant decrease in the expression and/or activity of SOD, catalase, glutathione S-transferase, and glutathione peroxidase in murine lungs and in the airways of children with severe bronchiolitis. Markers of oxidative damage correlated with severity of clinical illness in RSV-infected infants. Nrf2 expression was also significantly reduced in the lungs of viral-infected mice. RSV infection induces significant down-regulation of the airway antioxidant system in vivo, likely resulting in lung oxidative damage. Modulation of oxidative stress may pave the way toward important advances in the therapeutic approach of RSV-induced acute lung disease.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Supported by National Institutes of Health grants AI062885, AI30039, HV28184, UL1RR029876, by Department of Defense W81XWH1010146, and by Flight Attendant Medical Research Institute (FAMRI) Clinical Innovator Awards 072147 (A.C.) and 42253 (R.P.G.). P.D.J. and D.L.E. were supported by Postdoctoral Fellowships from the National Institute of Environmental Health Sciences (T32–07254).
This article has an online supplement, which is accessible from this issue's table of contents at www.atsjournals.org
Author Disclosure: Y.M.H. does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript. P.D.J. does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript. D.L.E. does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript. H.S. does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript. A.K. does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript. A.C. received grant support from the Department of Defense and the Flight Attendant Medical Research Institute. R.P.G. received grant support from the Department of Defense, the Flight Attendant Medical Research Institute, and NASA.
Originally Published in Press as DOI: 10.1164/rccm.201010-1755OC on March 4, 2011
ISSN:1073-449X
1535-4970
DOI:10.1164/rccm.201010-1755OC